These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1. Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S. J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988 [Abstract] [Full Text] [Related]
9. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. Takahashi H, Houghten R, Putney SD, Margulies DH, Moss B, Germain RN, Berzofsky JA. J Exp Med; 1989 Dec 01; 170(6):2023-35. PubMed ID: 2479705 [Abstract] [Full Text] [Related]
10. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Bergmann C, Stohlmann SA, McMillan M. Eur J Immunol; 1993 Nov 01; 23(11):2777-81. PubMed ID: 7693478 [Abstract] [Full Text] [Related]
11. Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop. Shirai M, Kozlowski S, Margulies DH, Berzofsky JA. J Immunol; 1997 Apr 01; 158(7):3181-8. PubMed ID: 9120272 [Abstract] [Full Text] [Related]
12. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Brander C, Pichler WJ, Corradin G. Clin Exp Immunol; 1995 Jul 01; 101(1):107-13. PubMed ID: 7621579 [Abstract] [Full Text] [Related]
13. Analysis of the extracellular processing of HIV-1 gp160-derived peptides using monoclonal antibodies specific to H-2Dd molecule complexed with p18-I10 peptide. Poláková K, Russ G. Acta Virol; 2001 Jul 01; 45(4):227-34. PubMed ID: 11885929 [Abstract] [Full Text] [Related]
16. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Sandberg JK, Leandersson AC, Devito C, Kohleisen B, Erfle V, Achour A, Levi M, Schwartz S, Kärre K, Wahren B, Hinkula J. Virology; 2000 Jul 20; 273(1):112-9. PubMed ID: 10891413 [Abstract] [Full Text] [Related]
17. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review. Becker Y. Virus Genes; 1994 Jul 20; 8(3):249-70. PubMed ID: 7975271 [Abstract] [Full Text] [Related]
18. Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160. Shirai M, Kurokohchi K, Pendleton CD, Arichi T, Boyd LF, Takahashi H, Margulies DH, Berzofsky JA. J Immunol; 1996 Nov 15; 157(10):4399-411. PubMed ID: 8906815 [Abstract] [Full Text] [Related]
19. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA. Int Immunol; 1993 Aug 15; 5(8):849-57. PubMed ID: 8398980 [Abstract] [Full Text] [Related]
20. Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules. Takeshita T, Kozlowski S, England RD, Brower R, Schneck J, Takahashi H, DeLisi C, Margulies DH, Berzofsky JA. Int Immunol; 1993 Sep 15; 5(9):1129-38. PubMed ID: 8241055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]